Black Rock Inc. Bio N Tech Se Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Black Rock Inc. holds 1,895,427 shares of BNTX stock, worth $196 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,895,427
Previous 1,906,841
0.6%
Holding current value
$196 Million
Previous $176 Million
13.41%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BNTX
# of Institutions
319Shares Held
40.9MCall Options Held
1.38MPut Options Held
1.52M-
Baillie Gifford & CO8.04MShares$832 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$438 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$414 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$372 Million0.24% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.51MShares$156 Million0.79% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...